Clinical trials
Phase 1 trials in Ireland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 3 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 8 |
| Terminated | 5 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Trials Ireland | 5 |
| St Patrick's Hospital, Ireland | 4 |
| Eli Lilly and Company | 3 |
| National University of Ireland, Galway, Ireland | 3 |
| Bayer | 2 |
| Bristol-Myers Squibb | 2 |
| Children's Cancer and Leukaemia Group | 2 |
| Johnson & Johnson Consumer and Personal Products Worldwide | 2 |
| Minerva Neurosciences | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 6 |
| Breast Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Multiple Myeloma | 4 |
| Neoplasms | 4 |
| Amyotrophic Lateral Sclerosis | 2 |
| Central Nervous System Neoplasms | 2 |
| Coronary Artery Disease | 2 |
| Depressive Disorder | 2 |
| Fallopian Tube Neoplasms | 2 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.